Abstract
The sheep model of allergic bronchoconstriction has been extensively used to study the pathobiology of asthma, but may be most noted for its use as a model of antigen-induced late phase airway responses (late asthmatic response, LAR). The intense interest in the late response is, in part, due to epidemiological data which suggest that patients who develop late antigen-induced responses in the laboratory suffer from more severe asthma [1]. Thus, understanding the mechanisms leading to the development of late responses could be important in identifying factors that influence asthma severity. The following chapter provides a summary of the pathophysiological and pharmacological studies in the sheep model and how these studies have been used to understand the mechanisms operative in allergic bronchoconstriction and inflammation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
O’Byrne PM, Dolovich J, Hargrave FE. State of Art: Late asthmatic responses. Am Rev Respir Dis 1987; 136: 740–751.
Abraham WM, Oliver W. Jr., Welker MJ, King M, Wanner A, Sackner MA. Differences in airway reactivity in normal and allergic sheep after exposure to sulfur dioxide. J Appl Physiol 1981; 51: 1651–1656.
Mansour E, Ahmed A, Cortes A, Caplan J, Burch RM, Abraham WM. Mechanisms of metabisulfite-induced bronchoconstriction: Evidence for bradykinin B2 receptor stimulation. J Appl Physiol 1992; 72: 1831–1837.
Abraham WM, Ahmed A, Cortes A, Soler M, Farmer SG, Baugh LE, et al. Airway effects of inhaled bradykinin, substance P, and neurokinin A in sheep. J Allergy Clin Immunol 1991; 87: 557–564.
Russi EW, Abraham WM, ChaPman GA, Stevenson JS, Codias E, Wanner A. Effects of leukotriene D4 on mucociliary and respiratory function in allergic and non-allergic sheep. J Appl Physiol 1985; 59: 1416–1422.
Abraham WM, Lanes S, Wanner A, Stevenson JS, Codias E, Yerger LD. Differences in airway responsiveness to leukotriene D4 in allergic sheep with and without late bronchial responses. Prostaglandins 1986; 31: 445–455.
Wanner A, Abraham WM. Experimental models of asthma. Lung 1982; 160: 231–243.
Ahmed T, Krainson JP, Yerger LD. Functional depression of H2 histamine receptors in sheep with experimental allergic asthma. J Allergy Clin Immunol 1983; 72: 310–320.
Wanner A, Reinhart M. Respiratory mechanics in conscious sheep. J Appl Physiol 1978; 44: 479–482.
Abraham WM, Delehunt JC, Yerger L, Marchette B. Characterization of a late phase pulmonary response following antigen challenge in allergic sheep. Am Rev Respir Dis 1983; 128: 839–844.
Lanes S, Stevenson JS, Codias E, Hernandez A, Sielczak MW, Wanner A, et al. Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep. J Appl Physiol 1986; 61: 864–872.
Delehunt JC, Perruchoud AP, Yerger L, Marchette B, Stevenson JS, Abraham WM. The role of SRS-A in the late bronchial response following antigen challenge in allergic sheep. Am Rev Respir Dis 1984; 130: 748–754.
Durham SR, Graneek BJ, Hawkins R, Taylor AJN. The temporal relationship between increases in airway responsiveness to histamine and late asthmatic responses induced by occupational agents. J Allergy Clin Immunol 1987; 79: 398–406.
Durham SR, Craddock CF, Cookson WO, Benson MK. Increases in airway responsive¬ness to histamine precede allergen-induced late asthmatic responses. J Allergy Clin Immunol 1988; 82: 764–770.
Abraham WM, Sielczak MW, Ahmed A, Cortes A, Lauredo IT, Kim J, et al. Alpha4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 1994; 93: 776–787.
Soler M, Sielczak MW, Abraham WM. A PAF-antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. J Appl Physiol 1989; 67: 406–413.
Abraham WM, Oliver W, Jr., King MM, Yerger L, Wanner A. Effect of pharmacologic agents on antigen-induced decreases in specific lung conductance in sheep. Am Rev Respir Dis 1981; 124: 554–558.
Abraham WM. The importance of lipoxygenase products of arachidonic acid in allergen- induced late responses. Am Rev Respir Dis 1987; 135: S49–53.
Brideau C, Chan C, Charleson S, Denis D, Evans JF, Ford-Hutchinson AW, et al. Pharmacology of MK-0591 (3-[l-4(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl- methoxy)-indol-2-yl]-2,2-dimethyl propanioc acid), a potent, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol 1992; 70: 799–807.
Tagari P, Abraham WM, McGoldrick J, Charleson S, Soler M, Ahmed A, et al. Increased leukotriene E4 excretion during antigen-induced bronchoconstriction in allergic sheep. J Appl Physiol 1990; 68: 1321–1327.
Russi EW, Perruchoud AP, Yerger LD, Stevenson JS, Tabak J, Marchette B, et al. Late phase bronchial obstruction following non-immunologic mast cell degranulation. J Appl Physiol 1984; 57: 1182–1188.
Abraham WM. The role of leukotrienes in allergen-induced late responses in allergic sheep. Annals of the New York Academy of Sciences: Biology of the Leukotrienes 1988; 524: 260–270.
Dworski R, Sheller JR, Wickersham NE, Oates JA, Bringham KL, Roberts LJ, et al. Allergen-stimulated release of mediators into sheep bronchoavlveolar lavage fluid. Effect of cyclooxygenase inhibition. Am Rev Respir Dis 1989; 139: 46–51.
Soler M, Perruchoud AP, Abraham WM. Antigen-induced late responses unmasked by indomethacin in allergic sheep are blocked by FPL-55712. Am Rev Respir Dis 1988; 137(2): 178.
Blinder L, Stevenson JS, Tallent MW, Jackowski JT, Wanner A, Ahmed T, et al. Cyclooxygenase products of arachidonate modulate antigen-induced late responses in the airways. Am Rev Respir Dis 1987; 135: A180.
Kirby JG, Hargreave FE, Cockcroft DW, O’Byrne PM. The effect of indomethacin on allergen-induced asthmatic responses. J Appl Physiol 1989; 66: 578–583.
Sladek K, Dworski R, Fitzgerald GA, Buitkus KL, Block FJ, Merney SR, et al. Allergen- stimulated release of thromboxane A2 and leukotriene E4 in humans. Am Rev Respir Dis 1990; 141: 1441–1445.
Ahmed T, Syriste T, Lucio J, Abraham W, Robinson M, D’Brot J. Inhibition of antigen-induced airway and cutaneous responses by heparin: a pharmacodynamic study. J Appl Physiol 1993; 74(4): 1492–1498.
Ahmed T, Syriste T, Mendelssohn R, Sorace D, Mansour E, Lansing M, et al. Heparin prevents antigen-induced airway hyperresponsiveness: Interference with IP3-mediated mast cell degranulation. J Appl Physiol 1994; 76: 893–901.
Lucio J, D’Brot J, Guo C, Abraham WM, Lichtenstein LM, Kagey-Sobotka A, et al. Immunologic mast cell-mediated responses and histamine release are attenuated by heparin. J Appl Physiol 1992; 73(3): 1093–1101.
D’Brot J, Abraham WM, Ahmed T. Effect of heparin on immunologic and non-immunologic bronchoconstrictor responses in allergic sheep with and without late responses. Am Rev Respir Dis 1991; 143: A540.
Abraham WM, Burch RM, Farmer SG, Sielczak MW, Ahmed A, Cortes A. A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep. Am Rev Respir Dis 1991; 143: 787–796.
Okayama H, Aikawa T, Ohtsu H, Sasaki H, Takishima T. Leukotriene C4 and B4 in bronchoalveolar lavage fluid during biphasic allergic bronchoconstriction in sheep. Am Rev Respir Dis 1989; 139: 725–731.
Clark JM, Abraham WM, Fishman CE, Forteza R, Ahmed A, Cortes A, et al. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 1995; 152: 2076–2083.
Abraham WM, Forteza R, Ahmed A, Cortes A. Neural mechanisms regulate the early and inflammatory cells the late increase in tissue kallikrein activity after local antigen challenge in allergic sheep. Am J Respir Crit Care Med 1994; 149(4): A533.
Abraham WM, Ahmed A, Cortes A, Delehunt JC. C-fiber desensitization prevents airway hypressesponsiveness to cholinerigic and antigenic stimuli after antigen challenge in allergic sheep. Am Rev Respir Dis 1993; 147: A478.
Naclerio RM, Proud D, Togias AG, Adkinson NF, Meyers DA, Kagey-Sobotka A, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313: 65–70.
Smith HR, Larsen GL, Cherniack RM. Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness. J Allergy Clin Immunol 1992; 89: 1076–1084.
Abraham WM. pharmacology of allergen-induced early and late airway responses and antigen-induced airway hyperresponsiveness in allergic sheep. Pulm Pharmacol 1989; 2: 33–40.
Wegner CD, Gundel RH, Abrhama WM, Schulman ES, Kontny MJ, Lazer ES, et al. The role of 5-lipoxygenase products in preclinical models of asthma. J Allergy Clin Immunol 1993; 91(4): 917–929.
Abraham WM, Ahmed A, Cortes A, Sielczak M, Hallmon J. The effects of a cysteinyl leukotriene antagonist (ONO-1078) on antigen-induced responses in allergic sheep. Prostaglandins, Leukotrienes and Essential Fatty Acids 1993; 48: 233–239.
Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, Zuraw BL. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis 1992; 145: 900–905.
Proud D, Vio CP. Localization of immunoreactive tissue kallikrein in human trachea. Am J Respir Cell Mol Biol 1993; 8: 16–19.
Pepys J, Hutchcroft BJ, Bronchial provocation tests in the etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 1975; 112: 829–859.
Nagy L, Lee TH, Kay AB. Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. N Engl J Med 1982; 306: 497–501.
Diaz P, Gonzalez MC, Galleguillos FR, Ancic P, Cromwell O, Shepherd D, et al. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late phase asthmatic reactions. Am rev Respir Dis 1989; 139: 1383–1389.
Soler M, Sielczak M, Abraham WM. Separation of late bronchial responses from airway hyperresponsiveness in allergic sheep. J Appl Physiol 1991; 70(2): 617–623.
Abraham WM, Stevenson JS, Garrido R. A leukotriene and thromboxane inhibitor (Sch 37224) blocks antigen-induced immediate and late responses and airway hyperresponsiveness in allergic sheep. J Pharmacol Exp Ther 1988; 247(3): 1004–1011.
Abraham WM, Ahmed A, Cortes A, Sielczak MW. The effect of a thromboxane endoperoxide receptor antagonist (BAY U3405) on antigen-induced airway responses in sheep. Am Rev Respir Dis 1992; 145: A291.
Noguchi K, Ishikawa K, Yano M, Ahmed A, Cortes A, Hallmon J, et al. An endothelin (ET)a receptor antagonist, BQ-123, blocks ET-1 induced bronchoconstriction and tracheal smooth muscle (TSM) contraction in allergic sheep. Am Rev Respir Dis 1992; 145(2): A858.
Noguchi K, Ishikawa K, Yano M, Ahmed A, Cortes A, Abraham WM, Endothelin-1 contributes to antigen induced airway hyperresponsiveness. J Appl Physiol 1995; 79: 700–705.
Cortes A, Ahmed A, Sielczak MW, Abraham WM. Reversal of antigen-induced airway hyperresponsiveness by a novel anti-allergic compound TYB-2285. Am Rev Respir Dis 1992; 145: A726.
Long WM, Yerger LD, Martinez H, Codias E, Sprung CL, Abraham WM, et al. Modification of bronchial blood flow during allergic airway responses. J Appl Physiol 1988; 65: 272–282.
Long WM, Yerger LD, Abraham WM, Lobel C. Late-phase bronchial vascular responses in allergic sheep. J Appl Physiol 1990; 69: 584–590.
Long WM, Cortes A, Jackowski JT, Abello R, Abraham WM. Pretreatment with FPL-55712, a leukotriene antagonist, prevents antigen-induced late phase increases in airflow resistance (RL) and bronchial artery blood flow (Qbr in allergic sheep. Fed Proc 1988; 2: A952.
Abraham WM, Sielczak MW, Wanner A, Perruchoud AP, Blinder L, Stevenson JS, et al. Cellular markers of inflammation in the airways of allergic sheep with and without allergen-induced late responses. Am Rev Respir Dis 1988; 138: 1565–1571.
Sielczak MW, Ahmed A, Abraham WM. Nedocromil sodium (NED) and methylpred- nisolone succinate (MPS) block bronchoalveolar lavage (BAL) eosinophilia produced by local bronchial antigen challenge in sheep. FASEB J 1991; 5: A1242.
Signoretti F, Sielczak MW, Ahmed A, Seybold Z, Stevenson JS, Abraham WM. Lung inflammatory cell changes after local antigen-challenge in allergic sheep with and without late airway responses. FASEB J 1988; 2: A1185.
Lobb RR, Hemler ME. The pathophysiologic role of a4 integrins in vivo. J Clin Invest 1994; 94: 1722–1728.
Abraham WM, Sturton RG, Palfai S, Taylor WA, Ahmed A, Cortes A, et al. Inhibition of antigen-induced late airway responses by a monoclonal antibody specific for the CD11/CD18 receptor on neutrophils (PMNs) in sheep. Am Rev Respir Dis 1991; 143: A539.
Soler M, Sielczak MW, Abraham WM. A bradykinin-antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pul Pharmacol 1990; 3: 9–15.
Lansing MW, Mansour E, Ahmed A, Cortes A, Garcia L, Lauredo IT, et al. Lipid mediators contribute to oxygen radical-induced airway responses in sheep. Am Rev Respir Dis 1991; 144: 1291–1296.
Lansing MW, Ahmed A, Cortes A, Sielczak MW, Wanner A, Abraham WM. Oxygen radicals contribute to antigen-induced airway hyperresponsiveness in conscious sheep. Am Rev Respir Dis 1993; 147: 321–326.
Abraham WM. The interaction among granulocyte lipid mediators and the generation of oxygen radicals in antigen-induced airway hyperresponsiveness. In: Dahlen SE, Hedqvist P, Samuelsson B, Taylor WA, Fritsch J, editors. Advances in prostaglandin, Thromboxane, and Leukotriene Research. New York: Raven Press, 1994: 131–140.
Abraham WM, Baugh LE. Animal models of asthma. In: Busse WW, Holgate ST, editors. Asthma and Rhinitis. Boston: Blackwell Scientific Publications, Inc. 1995: 961–977.
Allegra L, Abraham WM, Chapman GA, Wanner A. Duration of mucociliary dysfunction following antigen challenge. J Appl Physiol 1983; 55: 726–730.
Abraham WM, Wanner A, Stevenson JS, Chapman GA. The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep. Prostaglandins 1986; 31: 457–467.
Britto JR, Hanley SP, Tattersfield AE. The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma. J Allergy Clin Immunol 1987; 79: 811–816.
Bel EH, Timmers MC, Dijkman JH, Stahl EG, Sterk PJ. The effect of an inhaled leukotriene antagonist, L-648,051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in man. J Allergy Clin Immunol 1990; 85: 1067–1075.
Hendeles L, Davison D, Blake K, Harman E, Cooper R, Margolskee D. Leukotriene D4 is an important mediator of antigen-induced bronchoconstriction attenuation of dual response with MK-571, a specific LTD4 receptor antagonist. J Allergy Clin Immunol 1990; 85: 197.
Taylor IK, O’Shaughnessy KM, Fuller RW, Dollery CT. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991; 337: 690–694.
O’Shaughnessy KM, Taylor IK, O’Connor B, O’Connell F, Thomson H, Dollery CT. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction. Am Rev Respir Dis 1993; 147: 1431–1435.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Abraham, W.M. (1996). The Sheep as a Model of the Late Asthmatic Response. In: Raeburn, D., Giembycz, M.A. (eds) Airways Smooth Muscle: Modelling the Asthmatic Response In Vivo . Respiratory Pharmacology and Pharmacotherapy. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-9000-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-0348-9000-7_8
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-9863-8
Online ISBN: 978-3-0348-9000-7
eBook Packages: Springer Book Archive